Literature DB >> 9843559

Effects of pregnancy and chronic hypoxia on contractile responsiveness to alpha1-adrenergic stimulation.

M M White1, R E McCullough, R Dyckes, A D Robertson, L G Moore.   

Abstract

Decreased contractile response to vasoconstrictors in uterine and nonuterine vessels contributes to increased blood flow to the uterine circulation during normal pregnancy. Pregnancies complicated by preeclampsia and/or chronic hypoxia show a reversal or diminution of these pregnancy-associated changes. We sought to determine whether chronic hypoxia opposes the reduction in contractile response in uterine and nonuterine vessels during normal pregnancy and, if so, whether decreased basal nitric oxide (NO) activity was involved. We examined the contractile response to phenylephrine (PE) in guinea pig uterine artery (UA), mesenteric artery (MA), and thoracic aorta (TA) rings isolated from nonpregnant or pregnant guinea pigs that had been exposed throughout gestation to either low (1,600 m, n = 47) or high (3,962 m, n = 43) altitude. In the UA, pregnancy reduced contractile sensitivity to PE and did so similarly at low and high altitude (EC50: 4.0 x 10(-8) nonpregnant, 9.3 x 10(-8) pregnant at low altitude; 4.8 x 10(-8) nonpregnant, 1.0 x10(-8) pregnant at high altitude; both P < 0.05). Addition of the NO synthase inhibitor nitro-L-arginine (NLA; 200 mM) to the vessel bath increased contractile sensitivity in the pregnant UA (P < 0.05) and eliminated the effect of pregnancy at both altitutes. NLA also raised contractile sensitivity in the nonpregnant high-altitude UA, but contractile response without NLA did not differ in the high- and low-altitude animals. In the MA, pregnancy decreased contractile sensitivity to PE at high altitude only, and this shift was reversed by NO inhibition. In the TA, neither pregnancy nor altitude affected contractile response, but NO inhibition raised contractile response in nonpregnant and pregnant TA at both altitudes. We concluded that pregnancy diminished contractile response to PE in the UA, likely as a result of increased NO activity, and that these changes were similar at low and high altitude. Counter to our hypothesis, chronic hypoxia did not diminish the pregnancy-associated reduction in contractile sensitivity to PE or inhibit basal NO activity in the UA; rather it enhanced, not diminished, basal NO activity in the nonpregnant UA and the pregnant MA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9843559     DOI: 10.1152/jappl.1998.85.6.2322

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  5 in total

1.  Role of the AT2 receptor in modulating the angiotensin II contractile response of the uterine artery at mid-gestation.

Authors:  Victor M Pulgar; Henry Yamashiro; James C Rose; Lorna G Moore
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2011-03-18       Impact factor: 1.636

2.  High Altitude Reduces NO-Dependent Myometrial Artery Vasodilator Response During Pregnancy.

Authors:  Ramón A Lorca; Sydney L Lane; Elise S Bales; Hisham Nsier; HeaMi Yi; Meghan A Donnelly; Anna G Euser; Colleen G Julian; Lorna G Moore
Journal:  Hypertension       Date:  2019-06       Impact factor: 10.190

3.  Chronic hypoxia alters vasoconstrictive responses of femoral artery in the fetal sheep.

Authors:  Yoon Ha Kim; Jean-Claude Veille; Moon Kyoung Cho; Myoung Seon Kang; Cheol Hong Kim; Tae-Bok Song; Jorge P Figueroa
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

4.  Epidermal growth factor and parathyroid hormone-related peptide mRNA in the mammary gland and their concentrations in milk: effects of postpartum hypoxia in lactating rats.

Authors:  E D Bruder; J Van Hoof; J B Young; H Raff
Journal:  Horm Metab Res       Date:  2008-03-06       Impact factor: 2.936

5.  Preeclampsia and eclampsia incidence in the eastern anatolia region of Turkey: the effects of high altitude.

Authors:  Yakup Kumtepe; Onur Dündar; Kadir Cetinkaya; Metin Ingeç
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-03-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.